Eli Lilly Eyes Label Expansion For Leukemia Drug

Eli Lilly and Co. (NYSE:LLY) said Sunday that its Phase 3 BRUIN CLL-322 trial met its primary endpoint, with the addition of Jaypirca (pirtobrutinib) to venetoclax and rituximab significantly improving progression-free survival in patients with relapsed or refractory...

Why Is PayPal Stock Gaining Monday?

PayPal Holdings Inc. (NASDAQ:PYPL) stock is surging on Monday. The upward price action stems primarily from disclosures that high-profile investor Michael Burry significantly increased his equity stake in the digital payments company. Burry Accumulates Battered PYPL...